These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25185975)

  • 1. Impact of alternative medical device approval processes on costs and health.
    George BP; Venkataraman V; Dorsey ER; Johnston SC
    Clin Transl Sci; 2014 Oct; 7(5):368-75. PubMed ID: 25185975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare's New Device-Coverage Pathway - Breakthrough or Breakdown?
    Rathi VK; Johnston JL; Ross JS; Dhruva SS
    N Engl J Med; 2021 Mar; 384(12):e43. PubMed ID: 33691059
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicare covers the majority of FDA-approved devices and Part B drugs, but restrictions and discrepancies remain.
    Chambers JD; May KE; Neumann PJ
    Health Aff (Millwood); 2013 Jun; 32(6):1109-15. PubMed ID: 23733986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic implications of potential changes to regulatory and reimbursement policies for medical devices.
    Reed SD; Shea AM; Schulman KA
    J Gen Intern Med; 2008 Jan; 23 Suppl 1(Suppl 1):50-6. PubMed ID: 18095045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generating appropriate clinical data for value assessment of medical devices: what role does regulation play?
    Tarricone R; Torbica A; Ferré F; Drummond M
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):707-18. PubMed ID: 25196848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balancing adoption and affordability of medical devices in Europe.
    Schreyögg J; Bäumler M; Busse R
    Health Policy; 2009 Oct; 92(2-3):218-24. PubMed ID: 19410326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and spillover effects of private insurers' coverage of hepatitis C treatment.
    Moreno GA; Mulligan K; Huber C; Linthicum MT; Dreyfus D; Juday T; Marx SE; Gonzalez YS; Brookmeyer R; Lakdawalla DN
    Am J Manag Care; 2016 May; 22(6 Spec No.):SP236-44. PubMed ID: 27266954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The limited state of technology assessment for medical devices: facing the issues.
    Ramsey SD; Luce BR; Deyo R; Franklin G
    Am J Manag Care; 1998 Sep; 4 Spec No():SP188-99. PubMed ID: 10185994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-approval studies in France, challenges facing medical devices.
    Levesque K; Coqueblin C; Guillot B; ; Aubourg L; Avouac B; Carbonneil C; Cucherat M; Descamps-Mandine P; Hanoka S; Goldberg M; Josseran A; Parquin F; Pitel S; Ratignier C; Sechoy O; Szwarcenstein K; Tanti A; Teiger E; Thevenet N
    Therapie; 2014; 69(4):303-21. PubMed ID: 25230354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving medical device regulation: the United States and Europe in perspective.
    Sorenson C; Drummond M
    Milbank Q; 2014 Mar; 92(1):114-50. PubMed ID: 24597558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The financing and regulation of medical devices in the United States.
    Sisk JE
    Med Prog Technol; 1982; 9(2-3):181-6. PubMed ID: 7162490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forcing isolation: Medicare's "in the home" coverage standard for wheelchairs.
    Medicare Rights Center
    Care Manag J; 2005; 6(1):29-37. PubMed ID: 16447855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pricing of medical devices under coverage uncertainty--a modelling approach.
    Girling AJ; Lilford RJ; Young TP
    Health Econ; 2012 Dec; 21(12):1502-7. PubMed ID: 22021085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmarketing trials and pediatric device approvals.
    Hwang TJ; Kesselheim AS; Bourgeois FT
    Pediatrics; 2014 May; 133(5):e1197-202. PubMed ID: 24733871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does assessing the value for money of therapeutic medical devices require a flexible approach?
    Iglesias CP
    Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):21-32. PubMed ID: 25583537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Device evaluation and coverage policy in workers' compensation: examples from Washington State.
    Franklin GM; Lifka J; Milstein J
    Am J Manag Care; 1998 Sep; 4 Spec No():SP178-86. PubMed ID: 10185993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of new technology into clinical practice after FDA approval.
    Govil A; Hao SC
    J Interv Card Electrophysiol; 2016 Oct; 47(1):19-27. PubMed ID: 27565971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs, commitment and locality: a comparison of for-profit and not-for-profit health plans.
    Inquiry; 2004; 41(2):116-29. PubMed ID: 15449428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical device regulation for manufacturers.
    McAllister P; Jeswiet J
    Proc Inst Mech Eng H; 2003; 217(6):459-67. PubMed ID: 14702983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.